Heejung Kim

Dr. Heejung Kim

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HZHaozhao Zhang
Haozhao Zhang
MDMichael Dohopolski
Michael Dohopolski
SSStrahinja Stojadinovic
Strahinja Stojadinovic
LSLuiza Giuliani Schmitt
Luiza Giuliani Schmitt
SASoummitra Anand
Soummitra Anand
HPHao Peng
Hao Peng
Objectives: This retrospective study aims to develop a multiomics approach that integrates radiomics, dosiomics, and delta features to predict treatment responses in brain metastasis (BM) patients undergoing PULSAR. Methods: A retrospective study encompassing 39 BM patients with 69 lesions treated with PULSAR was undertaken. Radiomics, dosiomics, and delta features were extracted from both pre-treatment and intra-treatment MRI scans alongside dose distributions. Six individual models, alongside an ensemble feature selection (EFS) model, were evaluated. The classification task focused on distinguishing between two lesion groups based on whether they exhibited a volume reduction of more than 20% at follow-up. Performance metrics, including sensitivity, specificity, accuracy, precision, F1 score, and the area under the receiver operating characteristic (ROC) curve (AUC), were assessed. Results: The EFS model integrated the features from pre-treatment radiomics, pre-treatment dosiomics, intra-treatment radiomics, and delta radiomics. It outperformed six individual models, achieving an AUC of 0.979, accuracy of 0.917, and F1 score of 0.821. Among the top nine features of the EFS model, six features came from post-wavelet transformation and three from original images. Conclusions: The study demonstrated the feasibility of employing a data-driven multiomics approach to predict treatment outcomes in BM patients receiving PULSAR treatment. Integrating multiomics with intra-treatment decision support in PULSAR shows promise for optimizing patient management and reducing the risks of under- or over-treatment.

3 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DWDa Wang
Da Wang
HKHeejung Kim
Heejung Kim
TZTingliang Zhuang
Tingliang Zhuang
JVJustin Visak
Justin Visak
BCBin Cai
Bin Cai
MLMu-Han Lin
Mu-Han Lin
Treatment planning in the field of radiation therapy has evolved from three-dimensional (3D) planning to inverse planning and, most recently, to personalized adaptive radiotherapy (ART)